Green tea for cancer drug delivery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2014
Singapore: A group of researchers from Institute of Bioengineering and Nanotechnology (IBN) is using green tea ingredien...Read more
TauRx pumps $135mn to advance treatment for Alzheimer's disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015
Singapore: Singapore and Scotland based TauRx Pharmaceuticals, a clinical-stage biopharmaceutical company developing a n...Read more
NIH: Gilead's sofosbuvir + ribavirin cures hepatitis C
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Aug, 2013
Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...Read more
Daiichi forms new firm to treat muscular dystrophy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2013
Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innov...Read more
Sinovac to supply Hep A vaccine to Jiangsu province
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013
Singapore: Sinovac Biotech, a leading China-based vaccine manufacturer, has been selected by the Jiangsu Centers for Dis...Read more
Regeneus clears procedures to initiate Progenza trial for osteoarthritis treatment
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016
Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...Read more
Safety concerns delay launch of Pfizer's arthritis drug Xeljanz
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Singapore: Pfizer's high hopes for its JAK3 (Janus kinase) inhibitor, tofacitinib (tasocitinib, CP-690550), now branded ...Read more
Ampio takes drug candidate to preclinical stage
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2012
Singapore: Ampio Pharmaceuticals has taken its candidate NCE001 from its proprietary methylphenidate derivatives family ...Read more
FDA not in favour of Otsuka's kidney drug Tolvaptan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2013
Singapore: The US FDA Cardiovascular and Renal Drugs Advisory Committee has disapproved Japan-based Otsuka Pharmaceutic...Read more
Pfizer, Japanese firm to jointly asses mAB for tumor
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2014
Singapore: Global pharmaceutical company, Pfizer, and Japanese firm, Kyowa Hakko Kirin, are jointly assessing the therap...Read more
Hope for COPD: Network Verification Challenge
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2014
Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...Read more
Prana gets +ve results in phase II Huntington trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2014
Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...Read more
Novartis partners with TB alliance
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2014
Singapore: Novartis has partnered with Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tube...Read more
ShangPharma appoints new CSO, president
Drug Discovery | Influencers | By BioSpectrum Bureau | 0 Comment | 28 Oct, 2013
Singapore: China's ShangPharma appointed Dr Art Taveras as president and chief scientific officer (CSO). He will be resp...Read more
NUHS chief gets Singapore President's award
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2014
Singapore: Professor John Wong Eu-Li, currently chief executive of National University Health System (NUHS), Isabel Chan...Read more
Taiwan firm gets FDA nod for ph II trial of gout drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Dec, 2014
Singapore: Taiwan based TWi Pharmaceuticals has received US FDA and Taiwan FDA approval of a protocol for a Phase II cli...Read more
BMS takes on combination drug for cancer therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014
Singapore: Japan's Ono Pharmaceutical and Kyowa Hakko Kirin has partnered with Bristol-Myers Squibbs for Phase 1 clinica...Read more
Novartis acquires antibody technology license to develop cancer therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2013
Singapore: Novartis has acquired the license for exclusive right to use Antibody-Drug Conjugate (ADC) technology from ...Read more